03/11/2026
Cognitive impairment affects an estimated 40–60% of people living with multiple sclerosis, yet routine cognitive monitoring is still not consistently integrated into MS care.
A new clinical case study from Doctors Hospital at Renaissance (DHR Health) highlights how neurologist Dr. Roberto Alejandro Cruz, MD implemented standardized cognitive assessment across a high-volume neurology practice using BrainCheck Assess.
Key elements of the implementation:
• 1,000+ cognitive assessments completed in 2025
• Baseline testing at diagnosis with annual longitudinal monitoring
• Use across MS, Parkinson’s disease, and dementia populations
• Spanish-language assessment supporting a predominantly Hispanic patient population
As disease-modifying therapies reduce relapse activity, clinicians are increasingly focused on detecting progression independent of relapse activity (PIRA) — where cognitive decline occurs even when MRI findings remain stable.
Establishing objective cognitive baselines and tracking within-patient change may help clinicians identify subtle functional decline earlier.
Read the clinical case study: https://bit.ly/3OUInnD